2-(4-Bromophenyl)butanoic acid, 95.0%, 25g

2,4-Dichloro-5-iodo-7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidine, 98%, 25g

(2-(Benzyloxy)-5-formylphenyl)boronic acid, 96%, 25g

2-(BENZYLAMINO)CYCLOHEXANOL, 97.0%, 100mg

3'-Bromophenyl acetylene, 97.0%, 10g

1,1,2,2-Tetrafluoro-2-((1,1,1,2,3,3-hexafluoro-3-((1,2,2-trifluorovinyl)oxy)propan-2-yl)oxy)ethane-1-sulfonyl fluoride, 98%, 1g

Methyl 2-hydroxy-3-(2-oxoethyl)benzoate, 95.0%, 100mg

(R)-3-((2S,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-3,4,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol, 95+%, 1mg

2-Amino-6-chloronicotinamide, 95.0%, 250mg

Glycine, min 99%, pour synthèse, 25 kg, emballage plastique.

4,7-Diazaspiro[2.5]octan-8-one, 97.0%, 250mg

N-(2,6-Dioxopiperidin-3-yl)-2-phenylacetamide, 95.0%, 1mg

4-Chloro-3-(trifluoromethoxy)benzonitrile, 97.0%, 25g